warning about possible liver toxicity in patients taking Rezulin (troglitazone)

    Parke-Davis is warning about possible liver toxicity in patients taking Rezulin (troglitazone).

    This could be extremely important. Rezulin is being given to many type 2 diabetics since it came out last January.

    But now there are 35 reports of liver damage...resulting in one liver transplant and one death.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote